Author: admin

Ulcerated Necrobiosis Lipoidica Market to Expand Significantly by 2034, States DelveInsight Reports | Processa Pharmaceuticals

The Key Ulcerated Necrobiosis Lipoidica Companies in the marlet include – Processa Pharmaceuticals, and others.

 

DelveInsight’s “Ulcerated Necrobiosis Lipoidica Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Ulcerated Necrobiosis Lipoidica, historical and forecasted epidemiology as well as the Ulcerated Necrobiosis Lipoidica market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

To Know in detail about the Ulcerated Necrobiosis Lipoidica market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Ulcerated Necrobiosis Lipoidica Market Forecast

 

Some of the key facts of the Ulcerated Necrobiosis Lipoidica Market Report:

  • The Ulcerated Necrobiosis Lipoidica market size was valued ~USD 35 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034).

  • In 2023, the United States dominated the market within the 7MM, representing approximately 70% of the overall market share.

  • In 2023, the EU4 and the UK together generated an estimated USD 8 million, with projections indicating strong growth at a notable CAGR. Among European countries, Germany held the largest market share, followed by Spain, the UK, and France, with France having the smallest market share that year.

  • DelveInsight’s analysts estimated that approximately 57% of the total diagnosed prevalent cases of Ulcerated Necrobiosis Lipoidica (uNL) in the 7MM were reported in the United States. Their projections also suggested that in 2023, the EU4 and the UK collectively accounted for nearly 28,000 diagnosed prevalent cases of uNL.

  • DelveInsight’s analysts estimate that in 2023, there were approximately 256,000 diagnosed prevalent cases of Necrobiosis Lipoidica in the 7MM. Among these, the total diagnosed prevalent cases of Ulcerated Necrobiosis Lipoidica (uNL) were 88,000.

  • In 2023, the gender-specific cases of Ulcerated Necrobiosis Lipoidica (uNL) in the 7MM were approximately 200,000 for females and about 55,000 for males. These numbers are expected to rise during the forecast period from 2024 to 2034.

  • Key Ulcerated Necrobiosis Lipoidica Companies: Processa Pharmaceuticals, and others

  • Key Ulcerated Necrobiosis Lipoidica Therapies: PCS499, and others

  • The Ulcerated Necrobiosis Lipoidica market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Ulcerated Necrobiosis Lipoidica pipeline products will significantly revolutionize the Ulcerated Necrobiosis Lipoidica market dynamics.

 

Ulcerated Necrobiosis Lipoidica Overview

Ulcerated Necrobiosis Lipoidica is a severe form of Necrobiosis Lipoidica, a rare, chronic skin condition often associated with diabetes. It is characterized by yellow-brown, atrophic plaques that can break down into painful ulcers, increasing the risk of infection and delayed wound healing. This condition typically affects the lower legs and requires careful wound management and treatment to prevent complications.

 

Get a Free sample for the Ulcerated Necrobiosis Lipoidica Market Report:

https://www.delveinsight.com/report-store/ulcerated-necrobiosis-lipoidica-market

 

Ulcerated Necrobiosis Lipoidica Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Ulcerated Necrobiosis Lipoidica Epidemiology Segmentation:

The Ulcerated Necrobiosis Lipoidica market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

  • Total Prevalence of Ulcerated Necrobiosis Lipoidica

  • Prevalent Cases of Ulcerated Necrobiosis Lipoidica by severity

  • Gender-specific Prevalence of Ulcerated Necrobiosis Lipoidica

  • Diagnosed Cases of Episodic and Chronic Ulcerated Necrobiosis Lipoidica

 

Download the report to understand which factors are driving Ulcerated Necrobiosis Lipoidica epidemiology trends @ Ulcerated Necrobiosis Lipoidica Epidemiology Forecast

 

Ulcerated Necrobiosis Lipoidica Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Ulcerated Necrobiosis Lipoidica market or expected to get launched during the study period. The analysis covers Ulcerated Necrobiosis Lipoidica market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Ulcerated Necrobiosis Lipoidica Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Ulcerated Necrobiosis Lipoidica Therapies and Key Companies

  • PCS499: Processa Pharmaceuticals

 

Discover more about therapies set to grab major Ulcerated Necrobiosis Lipoidica market share @ Ulcerated Necrobiosis Lipoidica Treatment Market

 

Ulcerated Necrobiosis Lipoidica Market Drivers

  • Rising patient population

  • Currently used off-label therapies lack evidence-based treatment

  • Ongoing development of PCS499

Ulcerated Necrobiosis Lipoidica Market Barriers

  • Challenges in the management of the disease

  • Unavailability of studies to estimate disease burden

  • High development cost

 

Scope of the Ulcerated Necrobiosis Lipoidica Market Report

  • Study Period: 2020–2034

  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

  • Key Ulcerated Necrobiosis Lipoidica Companies: Processa Pharmaceuticals, and others

  • Key Ulcerated Necrobiosis Lipoidica Therapies: PCS499, and others

  • Ulcerated Necrobiosis Lipoidica Therapeutic Assessment: Ulcerated Necrobiosis Lipoidica current marketed and Ulcerated Necrobiosis Lipoidica emerging therapies

  • Ulcerated Necrobiosis Lipoidica Market Dynamics: Ulcerated Necrobiosis Lipoidica market drivers and Ulcerated Necrobiosis Lipoidica market barriers

  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

  • Ulcerated Necrobiosis Lipoidica Unmet Needs, KOL’s views, Analyst’s views, Ulcerated Necrobiosis Lipoidica Market Access and Reimbursement

 

To know more about Ulcerated Necrobiosis Lipoidica companies working in the treatment market, visit @ Ulcerated Necrobiosis Lipoidica Clinical Trials and Therapeutic Assessment

 

Table of Contents

1. Ulcerated Necrobiosis Lipoidica Market Report Introduction

2. Executive Summary for Ulcerated Necrobiosis Lipoidica

3. SWOT analysis of Ulcerated Necrobiosis Lipoidica

4. Ulcerated Necrobiosis Lipoidica Patient Share (%) Overview at a Glance

5. Ulcerated Necrobiosis Lipoidica Market Overview at a Glance

6. Ulcerated Necrobiosis Lipoidica Disease Background and Overview

7. Ulcerated Necrobiosis Lipoidica Epidemiology and Patient Population

8. Country-Specific Patient Population of Ulcerated Necrobiosis Lipoidica

9. Ulcerated Necrobiosis Lipoidica Current Treatment and Medical Practices

10. Ulcerated Necrobiosis Lipoidica Unmet Needs

11. Ulcerated Necrobiosis Lipoidica Emerging Therapies

12. Ulcerated Necrobiosis Lipoidica Market Outlook

13. Country-Wise Ulcerated Necrobiosis Lipoidica Market Analysis (2020–2034)

14. Ulcerated Necrobiosis Lipoidica Market Access and Reimbursement of Therapies

15. Ulcerated Necrobiosis Lipoidica Market Drivers

16. Ulcerated Necrobiosis Lipoidica Market Barriers

17. Ulcerated Necrobiosis Lipoidica Appendix

18. Ulcerated Necrobiosis Lipoidica Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

 

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Ulcerated Necrobiosis Lipoidica Market to Expand Significantly by 2034, States DelveInsight Reports | Processa Pharmaceuticals

Onycholysis Market Forecasted to Surge in Coming Years, 2023-2032 Analysis by DelveInsight | Pfizer

The Key Onycholysis Companies in the market incude – Pfizer, and others.

 

DelveInsight’s “Onycholysis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Onycholysis, historical and forecasted epidemiology as well as the Onycholysis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

The latest healthcare forecast report provides an in-depth analysis of Onycholysis, offering comprehensive insights into the Onycholysis revenue trends, prevalence, and treatment landscape. The report delves into key Onycholysis statistics, highlighting the current and projected market size, while examining the efficacy and development of emerging Onycholysis therapies. Additionally, we cover the landscape of Onycholysis clinical trials, providing an overview of ongoing and upcoming studies that are poised to shape the future of Onycholysis treatment. This report is an essential resource for understanding the market dynamics and the evolving therapeutic options within the Onycholysis space.

 

To Know in detail about the Onycholysis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Onycholysis Market Forecast

 

Some of the key facts of the Onycholysis Market Report:

  • The Onycholysis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)

  • Key Onycholysis Companies: Pfizer, and others

  • Key Onycholysis Therapies: AN2690, and others

  • The Onycholysis market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Onycholysis pipeline products will significantly revolutionize the Onycholysis market dynamics.

 

Onycholysis Overview

Onycholysis is a nail disorder where the nail separates from the nail bed, creating a gap that may appear white, yellow, or green due to bacterial or fungal infections. It commonly affects fingernails but can also occur in toenails. Causes include trauma, frequent exposure to moisture, fungal infections, psoriasis, and certain medications. While generally painless, onycholysis can lead to discomfort if left untreated. Management involves addressing the underlying cause, maintaining good nail hygiene, and avoiding irritants to promote nail regrowth.

 

Get a Free sample for the Onycholysis Market Forecast, Size & Share Analysis Report:

https://www.delveinsight.com/report-store/onycholysis-market

 

Onycholysis Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Onycholysis Epidemiology Segmentation:

The Onycholysis market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Onycholysis

  • Prevalent Cases of Onycholysis by severity

  • Gender-specific Prevalence of Onycholysis

  • Diagnosed Cases of Episodic and Chronic Onycholysis

 

Download the report to understand which factors are driving Onycholysis epidemiology trends @ Onycholysis Epidemiology Forecast

 

Onycholysis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Onycholysis market or expected to get launched during the study period. The analysis covers Onycholysis market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Onycholysis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Onycholysis Therapies and Key Companies

  • AN2690: Pfizer

 

Discover more about therapies set to grab major Onycholysis market share @ Onycholysis Treatment Landscape

 

Onycholysis Market Drivers

  • Rising Dermatological Disorders

  • Advancements in Treatment Options

  • Growing Awareness

  • Expanding Geriatric Population

  • Improved Healthcare Access

 

Onycholysis Market Barriers

  • Lack of Specific Treatments

  • Misdiagnosis and Underreporting

  • High Treatment Costs

  • Limited Awareness in Developing Regions

  • Side Effects of Medications

 

Scope of the Onycholysis Market Report

  • Study Period: 2019–2032

  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

  • Key Onycholysis Companies: Pfizer, and others

  • Key Onycholysis Therapies: AN2690, and others

  • Onycholysis Therapeutic Assessment: Onycholysis current marketed and Onycholysis emerging therapies

  • Onycholysis Market Dynamics: Onycholysis market drivers and Onycholysis market barriers

  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

  • Onycholysis Unmet Needs, KOL’s views, Analyst’s views, Onycholysis Market Access and Reimbursement

 

To know more about Onycholysis companies working in the treatment market, visit @ Onycholysis Clinical Trials and Therapeutic Assessment

 

Table of Contents

1. Onycholysis Market Report Introduction

2. Executive Summary for Onycholysis

3. SWOT analysis of Onycholysis

4. Onycholysis Patient Share (%) Overview at a Glance

5. Onycholysis Market Overview at a Glance

6. Onycholysis Disease Background and Overview

7. Onycholysis Epidemiology and Patient Population

8. Country-Specific Patient Population of Onycholysis

9. Onycholysis Current Treatment and Medical Practices

10. Onycholysis Unmet Needs

11. Onycholysis Emerging Therapies

12. Onycholysis Market Outlook

13. Country-Wise Onycholysis Market Analysis (2019–2032)

14. Onycholysis Market Access and Reimbursement of Therapies

15. Onycholysis Market Drivers

16. Onycholysis Market Barriers

17. Onycholysis Appendix

18. Onycholysis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

 

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Onycholysis Market Forecasted to Surge in Coming Years, 2023-2032 Analysis by DelveInsight | Pfizer

Necrobiosis Lipoidica Diabeticorum Market Anticipated to Expand Rapidly During 2023-2032, Says DelveInsight | Processa Pharmaceuticals

The Key Necrobiosis Lipoidica Diabeticorum Companies in the market include – Processa Pharmaceuticals, and others.

 

DelveInsight’s “Necrobiosis Lipoidica Diabeticorum Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Necrobiosis Lipoidica Diabeticorum, historical and forecasted epidemiology as well as the Necrobiosis Lipoidica Diabeticorum market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

To Know in detail about the Necrobiosis Lipoidica Diabeticorum market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Necrobiosis Lipoidica Diabeticorum Market Forecast

 

Some of the key facts of the Necrobiosis Lipoidica Diabeticorum Market Report:

  • The Necrobiosis Lipoidica Diabeticorum market size is anticipated to grow with a significant CAGR during the study period (2019-2032).

  • Key Necrobiosis Lipoidica Diabeticorum Companies: Processa Pharmaceuticals, and others

  • Key Necrobiosis Lipoidica Diabeticorum Therapies: PCS499, and others

  • The Necrobiosis Lipoidica Diabeticorum market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Necrobiosis Lipoidica Diabeticorum pipeline products will significantly revolutionize the Necrobiosis Lipoidica Diabeticorum market dynamics.

 

Necrobiosis Lipoidica Diabeticorum Overview

Necrobiosis Lipoidica Diabeticorum (NLD) is a rare, chronic skin condition primarily associated with diabetes. It is characterized by yellowish-brown, atrophic plaques that commonly appear on the shins. The condition results from collagen degeneration, inflammation, and changes in blood vessels, leading to thinning skin that may ulcerate over time. While the exact cause is unknown, NLD is believed to be linked to microvascular complications in diabetes. Though it is not exclusive to diabetic patients, those with diabetes are at a higher risk. Treatment focuses on managing underlying diabetes, topical corticosteroids, and wound care if ulcers develop

 

Get a Free sample for the Necrobiosis Lipoidica Diabeticorum Market Report:

https://www.delveinsight.com/report-store/necrobiosis-lipoidica-diabeticorum-nld-market

 

Necrobiosis Lipoidica Diabeticorum Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Necrobiosis Lipoidica Diabeticorum Epidemiology Segmentation:

The Necrobiosis Lipoidica Diabeticorum market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Necrobiosis Lipoidica Diabeticorum

  • Prevalent Cases of Necrobiosis Lipoidica Diabeticorum by severity

  • Gender-specific Prevalence of Necrobiosis Lipoidica Diabeticorum

  • Diagnosed Cases of Episodic and Chronic Necrobiosis Lipoidica Diabeticorum

 

Download the report to understand which factors are driving Necrobiosis Lipoidica Diabeticorum epidemiology trends @ Necrobiosis Lipoidica Diabeticorum Epidemiology Forecast

 

Necrobiosis Lipoidica Diabeticorum Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Necrobiosis Lipoidica Diabeticorum market or expected to get launched during the study period. The analysis covers Necrobiosis Lipoidica Diabeticorum market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Necrobiosis Lipoidica Diabeticorum Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Necrobiosis Lipoidica Diabeticorum Therapies and Key Companies

  • PCS499: Processa Pharmaceuticals

 

Discover more about therapies set to grab major Necrobiosis Lipoidica Diabeticorum market share @ Necrobiosis Lipoidica Diabeticorum Treatment Market

 

Necrobiosis Lipoidica Diabeticorum Market Drivers

  • Rising patient population

  • Currently used off-label therapies lack evidence-based treatment

  • Ongoing development of PCS499

 

Necrobiosis Lipoidica Diabeticorum Market Barriers

  • Challenges in the management of the disease

  • Unavailability of studies to estimate disease burden

  • High development cost

 

Scope of the Necrobiosis Lipoidica Diabeticorum Market Report

  • Study Period: 2019–2032

  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

  • Key Necrobiosis Lipoidica Diabeticorum Companies: Processa Pharmaceuticals, and others

  • Key Necrobiosis Lipoidica Diabeticorum Therapies: PCS499, and others

  • Necrobiosis Lipoidica Diabeticorum Therapeutic Assessment: Necrobiosis Lipoidica Diabeticorum current marketed and Necrobiosis Lipoidica Diabeticorum emerging therapies

  • Necrobiosis Lipoidica Diabeticorum Market Dynamics: Necrobiosis Lipoidica Diabeticorum market drivers and Necrobiosis Lipoidica Diabeticorum market barriers

  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

  • Necrobiosis Lipoidica Diabeticorum Unmet Needs, KOL’s views, Analyst’s views, Necrobiosis Lipoidica Diabeticorum Market Access and Reimbursement

 

To know more about Necrobiosis Lipoidica Diabeticorum companies working in the treatment market, visit @ Necrobiosis Lipoidica Diabeticorum Clinical Trials and Therapeutic Assessment

 

Table of Contents

1. Necrobiosis Lipoidica Diabeticorum Market Report Introduction

2. Executive Summary for Necrobiosis Lipoidica Diabeticorum

3. SWOT analysis of Necrobiosis Lipoidica Diabeticorum

4. Necrobiosis Lipoidica Diabeticorum Patient Share (%) Overview at a Glance

5. Necrobiosis Lipoidica Diabeticorum Market Overview at a Glance

6. Necrobiosis Lipoidica Diabeticorum Disease Background and Overview

7. Necrobiosis Lipoidica Diabeticorum Epidemiology and Patient Population

8. Country-Specific Patient Population of Necrobiosis Lipoidica Diabeticorum

9. Necrobiosis Lipoidica Diabeticorum Current Treatment and Medical Practices

10. Necrobiosis Lipoidica Diabeticorum Unmet Needs

11. Necrobiosis Lipoidica Diabeticorum Emerging Therapies

12. Necrobiosis Lipoidica Diabeticorum Market Outlook

13. Country-Wise Necrobiosis Lipoidica Diabeticorum Market Analysis (2019–2032)

14. Necrobiosis Lipoidica Diabeticorum Market Access and Reimbursement of Therapies

15. Necrobiosis Lipoidica Diabeticorum Market Drivers

16. Necrobiosis Lipoidica Diabeticorum Market Barriers

17. Necrobiosis Lipoidica Diabeticorum Appendix

18. Necrobiosis Lipoidica Diabeticorum Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

 

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Necrobiosis Lipoidica Diabeticorum Market Anticipated to Expand Rapidly During 2023-2032, Says DelveInsight | Processa Pharmaceuticals

“Kinghelm Cup” 2025 Songgang Zhongqing Basketball Tournament Ends Successfully

image.png

Group Photo

On March 1st, after two weeks of exciting games, the “Kinghelm Cup” 2025 Songgang Zhongqing Basketball Tournament came to a successful close! Hosted by Songgang Zhongqing and sponsored by Kinghelm Electronics, this event brought together eight teams with players from across China, celebrating brotherhood, fitness, and fun through basketball.

image.png

Group photo of all-stars of the “Kinghelm Cup”

A Tournament of Friendship & Sportsmanship

Many participants were business owners aged 40-60, playing not for professional competition but for the love of the game, teamwork, and a healthy lifestyle. Across 29 matches, they showcased fair play, teamwork, and determination, building strong friendships and promoting a positive sports culture.

image.png

The scene of the competition

Special Guests & Awards

· Kinghelm Sales Directors Deng Haifeng & Chen Suwei attended the opening ceremony.

· Kinghelm & Slkor Founder Song Shiqiang joined the closing ceremony, presenting the MVP award and champion trophy.

· The tournament featured various awards, including Best Team, Best Sportsmanship, Best Coach, and Best Fitness Award, ensuring every player was recognized.

image.png

Mr. Song Shiqiang, General Manager of Kinghelm and SlkorMicro and Deng Haifeng of Kinghelm Electronics delivered speeches.

Kinghelm & Slkor: Supporting Sports & Health

At Kinghelm and Slkor, we believe in an active and energetic corporate culture. Our Kinghelm Badminton Team and Slkor Warriors Basketball Team keep our teams engaged and motivated. This sponsorship reflects our commitment to teamwork, fitness, and community spirit.

image.png

Mr. Song Shiqiang (first on the right) took a group photo and presented awards to the MVP winner

Connecting the World Through Basketball

Following Slkor’s sponsorship last year, Kinghelm proudly took the lead in 2025. As Song Shiqiang stated, we aim to promote friendly, healthy, and exciting basketball events. Looking ahead, we hope to expand our sponsorships and bring these tournaments to national TV, further strengthening our global presence.

image.png

Mr. Song Shiqiang (in the middle) took a group photo with the championship team

Kinghelm – Connecting the World, On and Off the Court!

image.png

Kinghelm was honored as the “Gold Medal Title Sponsor”

About Kinghelm

Kinghelm is a leading provider of high-quality electronic components, including RoHS-compliant antennas, wires, plug-ins, switches, and connectors. With over 17 years of experience, the company serves industries including automotive, telecommunications, industrial automation, medical devices, and consumer electronics. Kinghelm is known for its durable, reliable components that meet international standards and are used in applications ranging from renewable energy to IoT devices.

image.png

Kinghelm: A Replaceable Option for TE

Media Contact
Company Name: Shenzhen Kinghelm Electronics Co., Ltd.
Contact Person: Support
Email: Send Email
Phone: +86 0755-83975897
Address:2010, Block A, Bairuida Building Vanke City Community Bantian Avenue, Longgang District
City: Shenzhen
Country: China
Website: www.kinghelm.net

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: “Kinghelm Cup” 2025 Songgang Zhongqing Basketball Tournament Ends Successfully

Not Today by Dirk Reddings: A Riveting Thriller of Survival, Determination, and the Pursuit of Justice

“by Dirk Reddings”

In a story where every second counts, Not Today by Dirk Reddings delivers an intense and suspenseful narrative that explores the depths of human resilience and the unbreakable bond between a mother and daughter. This novel presents a gripping exploration of crime, survival, and the relentless pursuit of justice in the face of unimaginable darkness.

A Desperate Search Begins

When Maddie Simmons, a college student with a promising future, suddenly disappears, her mother, Dana Simmons, is thrust into a terrifying reality. The initial police response offers little comfort, with reassurances that do not match Dana’s growing fear. As evidence emerges that Maddie’s abduction was not a random act, Dana refuses to remain passive, launching her own search alongside Maddie’s closest friends and Tyson Bird, a determined private investigator.

As the investigation unfolds, a complex and sinister web begins to take shape. Every lead reveals new dangers, every step forward exposes another layer of deception. The predator responsible has meticulously planned each move, staying ahead of those searching for Maddie. The novel follows Dana’s relentless determination to uncover the truth, highlighting the emotional and psychological toll of fighting against time and uncertainty.

A Story of Strength and Unyielding Resolve

Not Today explores the extreme lengths a parent will go to in the name of love, the power of community in times of crisis, and the ethical dilemmas that arise when justice is not easily attained. The novel immerses readers in the emotional intensity of the search, depicting the struggles of those left behind, the complexities of law enforcement efforts, and the calculated mind of a criminal who thrives on control.

Dirk Reddings presents a masterfully written thriller that does not merely entertain but also examines themes of perseverance, morality, and the human will to survive. Not Today is a story that challenges assumptions, keeps readers on edge, and delivers a powerful message about courage in the face of overwhelming adversity.

Availability and Media Inquiries

Not Today is available in bookstores and through online retailers.

Amazon https://a.co/d/efr42lX

Media Contact
Company Name: Book Writing Genie
Contact Person: Dirk Reddings
Email: Send Email
Country: United States
Website: https://bookwritinggenie.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Not Today by Dirk Reddings: A Riveting Thriller of Survival, Determination, and the Pursuit of Justice

Burns Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2024-2034), States DelveInsight | Skingenix, RenovaCare, CUTISS AG, Argle Therapeutics, Medline Industries

The Key Burns Companies in the market include – Kerecis, Mallinckrodt Pharmaceuticals, Skingenix, RenovaCare, CUTISS AG, Argle Therapeutics, Medline Industries, Amryt Pharma, MediWound Ltd, MediWound Ltd, Cumberland Pharmaceuticals, Pfizer, Kuros Biosurgery AG, Bayer, and others.

 

DelveInsight’s “Burns Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Burns, historical and forecasted epidemiology as well as the Burns market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

To Know in detail about the Burns market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Burns Market Forecast

 

Some of the key facts of the Burns Market Report:

  • The Burns market size was valued approximately ~USD 1,577 Million 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)

  • In August 2024, MediWound Ltd. (Nasdaq: MDWD), a leading company in enzymatic therapeutics for tissue repair, announced that the U.S. Food and Drug Administration (FDA) has granted approval for a pediatric indication of NexoBrid® (anacaulase-bcdb). This approval permits its use for eschar removal in pediatric patients, from newborns to 18 years old, with deep partial- and full-thickness thermal burns.

  • In 2023, the market size in the EU4 and the UK was approximately USD 501 million, representing about 32% of the total market size in the 7MM.

  • Within the EU4 and the UK, the United Kingdom had the largest market size at around USD 165 million, followed by France at approximately USD 104 million and Germany at USD 87 million. These figures are expected to change during the forecast period.

  • In 2023, the burns market size in Japan represented about 14% of the total market size in the 7MM, with anticipated changes by 2034.

  • In 2023, there were approximately 5.4 million reported incident cases of burn injuries, with about 1.8 million requiring medical treatment across the 7MM. This number is projected to rise by 2034 due to an increase in industrial accidents, household incidents, and natural disasters.

  • The number of hospitalized burn cases in the 7MM market is anticipated to grow at a compound annual growth rate (CAGR) of 0.54% during the study period from 2020 to 2034.

  • In 2023, the US reported the highest number of burn injuries requiring medical treatment, with around 671,128 cases, followed by Japan with approximately 329,241 cases and the UK with 280,817 cases.

  • Among the EU4 and the UK, the UK had the highest number of burn patients needing medical treatment, with approximately 280,817 cases, followed by France and Spain with around 204,506 and 145,510 cases.

  • Key Burns Companies: Kerecis, Mallinckrodt Pharmaceuticals, Skingenix, RenovaCare, CUTISS AG, Argle Therapeutics, Medline Industries, Amryt Pharma, MediWound Ltd, MediWound Ltd, Cumberland Pharmaceuticals, Pfizer, Kuros Biosurgery AG, Bayer, and others

  • Key Burns Therapies: Kerecis Omega3, StrataGraft, MW-III, CellMist System, EHSG-KF (denovoSkin), AGLE-102, PluroGel, Oleogel-S10, DGD, NexoBrid, Caldolor, linezolid, I-020502, Ciprofloxacin (BAYO9867), and others

  • The Burns epidemiology based on gender analyzed that in the 7MM males contributes to higher incident cases as compared to females

  • The Burns market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Burns pipeline products will significantly revolutionize the Burns market dynamics.

 

Burns Overview

Burns are injuries to the skin or other tissues caused by exposure to heat, electricity, chemicals, or radiation. They can range from mild to severe and are classified based on their depth and extent

 

Get a Free sample for the Burns Market Report:

https://www.delveinsight.com/report-store/burns-market

 

Burns Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Burns Epidemiology Segmentation:

The Burns market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

  • Total Prevalence of Burns

  • Prevalent Cases of Burns by severity

  • Gender-specific Prevalence of Burns

  • Diagnosed Cases of Episodic and Chronic Burns

 

Download the report to understand which factors are driving Burns epidemiology trends @ Burns Epidemiology Forecast

 

Burns Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Burns market or expected to get launched during the study period. The analysis covers Burns market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Burns Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Burns Therapies and Key Companies

  • Kerecis Omega3: Kerecis

  • StrataGraft: Mallinckrodt Pharmaceuticals

  • MW-III: Skingenix

  • CellMist System: RenovaCare

  • EHSG-KF (denovoSkin): CUTISS AG

  • AGLE-102: Argle Therapeutics

  • PluroGel: Medline Industries

  • Oleogel-S10: Amryt Pharma

  • DGD: MediWound Ltd

  • NexoBrid: MediWound Ltd

  • Caldolor: Cumberland Pharmaceuticals

  • linezolid: Pfizer

  • I-020502: Kuros Biosurgery AG

  • Ciprofloxacin (BAYO9867): Bayer

 

Discover more about therapies set to grab major Burns market share @ Burns Treatment Market

 

Burns Market Drivers

  • Ongoing researches to develop treatment for severely burned patients Abundance of approved therapies

  • Rising incidence

  • Advancements in burn care treatments and products

 

Burns Market Barriers

  • Complications associated with available therapies

  • Lack of cost effective treatment

  • Lack of robust clinical pipeline

  • Limited awareness on burn care

 

Scope of the Burns Market Report

  • Study Period: 2020–2034

  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

  • Key Burns Companies: Kerecis, Mallinckrodt Pharmaceuticals, Skingenix, RenovaCare, CUTISS AG, Argle Therapeutics, Medline Industries, Amryt Pharma, MediWound Ltd, MediWound Ltd, Cumberland Pharmaceuticals, Pfizer, Kuros Biosurgery AG, Bayer, and others

  • Key Burns Therapies: Kerecis Omega3, StrataGraft, MW-III, CellMist System, EHSG-KF (denovoSkin), AGLE-102, PluroGel, Oleogel-S10, DGD, NexoBrid, Caldolor, linezolid, I-020502, Ciprofloxacin (BAYO9867), and others

  • Burns Therapeutic Assessment: Burns current marketed and Burns emerging therapies

  • Burns Market Dynamics: Burns market drivers and Burns market barriers

  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

  • Burns Unmet Needs, KOL’s views, Analyst’s views, Burns Market Access and Reimbursement

 

To know more about Burns companies working in the treatment market, visit @ Burns Clinical Trials and Therapeutic Assessment

 

Table of Contents

1. Burns Market Report Introduction

2. Executive Summary for Burns

3. SWOT analysis of Burns

4. Burns Patient Share (%) Overview at a Glance

5. Burns Market Overview at a Glance

6. Burns Disease Background and Overview

7. Burns Epidemiology and Patient Population

8. Country-Specific Patient Population of Burns

9. Burns Current Treatment and Medical Practices

10. Burns Unmet Needs

11. Burns Emerging Therapies

12. Burns Market Outlook

13. Country-Wise Burns Market Analysis (2020–2034)

14. Burns Market Access and Reimbursement of Therapies

15. Burns Market Drivers

16. Burns Market Barriers

17. Burns Appendix

18. Burns Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

 

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Burns Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2024-2034), States DelveInsight | Skingenix, RenovaCare, CUTISS AG, Argle Therapeutics, Medline Industries

A Journey of Survival and Strength: New Book Explores the Power of Faith

“DURETI (MIMI) TADESSE”

Every fight for justice has a cost. The gripping new memoir, “Resilience: Turning Persecution into Purpose”, brings to life an unforgettable story of survival, faith, and the unbreakable human spirit. This harrowing yet inspiring account takes readers into the depths of adversity, exploring the sacrifices made in the pursuit of truth and justice.

From a childhood overshadowed by oppression to a life-threatening fight for freedom, the author recounts her extraordinary journey:

  • A Childhood Marked by Persecution – Growing up under a regime determined to erase her cultural and religious identity, she learned the harsh reality of injustice from an early age.
  • A Prisoner of Conscience – Standing against oppression came at a heavy price. Arrested, tortured, and subjected to inhumane conditions, she experienced firsthand the cruelty inflicted upon those who dare to resist.
  • The Power of Faith and Community – In the darkest moments, whispered prayers, acts of defiance, and the solidarity of fellow prisoners kept hope alive.
  • Bearing Witness to the Cost of Oppression – The memoir sheds light on the silent suffering of countless others—lives lost, families shattered, and voices silenced by fear.
  • From Pain to Purpose – Emerging from suffering, she transformed her experience into a force for change, becoming an advocate for justice and a voice for the voiceless.


A Story That Demands to Be Heard

More than just a personal account, Resilience: Turning Persecution into Purpose is a testament to the endurance of the human spirit. It is a call to action for those who believe in justice, faith, and the power of resilience. With unflinching honesty and emotional depth, this book offers a beacon of hope to anyone facing adversity, proving that even in the face of unimaginable trials, the human will to survive and thrive remains unshaken.

Available Now

Resilience: Turning Persecution into Purpose is available in paperback, eBook, and audiobook formats. Readers seeking a story of courage, faith, and transformation will find this memoir deeply moving and profoundly relevant.

Amazon https://a.co/d/g2F5ckr

Media Contact
Company Name: Hemingway Publishers
Contact Person: Dureti (Mimi) Tadesse
Email: Send Email
Country: United States
Website: https://hemingwaypublishers.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: A Journey of Survival and Strength: New Book Explores the Power of Faith

The Rise of Abiidaan – The New Generation Superstar

The entertainment industry has a new rising star, and his name is Abiidaan. At just 24 years old, he has already made a remarkable impact across multiple fields, earning his place as a versatile and dynamic performer.

A master of blending entertainment with authenticity, Abiidaan’s content ranges from lifestyle and fashion to humor and daily insights, resonating with audiences across demographics. His charisma and ability to connect with fans have made him a popular influencer.

“Social media is more than just a platform for entertainment—it’s a way to build meaningful connections with people worldwide,” said Abiidaan. “I strive to create content that is not only engaging but also relatable and inspiring.”

With an ever-growing fan base and increasing brand collaborations, Abiidaan is set to make an even bigger impact in the digital landscape. Brands looking for an energetic and authentic influencer to elevate their campaigns can connect with Abiidaan for strategic partnerships.

Abiidaan’s journey began in 2016 when his first singing video went viral, capturing the attention of thousands. With a passion for music and performance, he continued honing his craft year after year, transforming into a recognized name in entertainment. His dedication and talent have led him to some of the biggest stages, including a live TV singing show and a performance at the 2022 FIFA World Cup, a milestone that solidified his place among rising artists.

Beyond singing, Abiidaan has showcased his versatility as a stage actor, model, and social media personality. He has graced campaigns for well-known brands such as Splash and gained recognition as one of Snapchat’s top influencers. Additionally, he has stepped into the world of sports entertainment, participating in three boxing matches featuring content creators—proving his ability to engage audiences across different platforms.

With an ever-growing fan base and an unyielding drive for success, Abiidaan is setting his sights on becoming one of the biggest singing performers in the Middle East and beyond. As he continues to evolve and expand his career, his journey serves as an inspiration to young talents worldwide.

For updates on the life and work of Abiidaan, follow him on:

Snapchat: https://snapchat.com/t/yrJehEl3

TikTok: https://www.tiktok.com/@abiidaan

Media Contact
Company Name: Coneberry
Contact Person: Ray
Email: Send Email
City: Abu Dhabi
State:
Country: United Arab Emirates
Website: coneberry.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Rise of Abiidaan – The New Generation Superstar

Houston Mermaids Brings the Magic of the Sea to Summer Celebrations

Houston’s Premier Mermaid Entertainment Company Makes a Splash.

As summer approaches, Houston Mermaids is ready to make waves, bringing unique and immersive entertainment to parties and events across the Greater Houston area. As the pioneer mermaid company in Houston, Houston Mermaids specializes in transforming ordinary gatherings into enchanting, aquatic adventures.

With professionally trained mermaids performing in high-quality, realistic tails, Houston Mermaids offers an unforgettable experience for children and guests of all ages. Whether in the water or on land, their interactive performances feature captivating sea stories, sing-alongs, interactive games, and stunning mermaid tail tricks. Attendees can experience mermaid training, swimming alongside skilled performers and enjoying an unforgettable aquatic adventure.

“Our vision is to create unforgettable event experiences that will be remembered for years to come,” said a spokesperson for Houston Mermaids. “We take pride in bringing something truly special to celebrations, whether it’s a child’s birthday, a community festival, or a corporate gathering. Our goal is to transport guests into a magical world where imagination and fun take center stage.”

Houston Mermaids caters to a variety of events, including birthday parties, personal celebrations, community gatherings, and corporate functions. Their services can be tailored to fit different event settings, whether at a private pool, a community venue, or a corporate function space. In addition to their mesmerizing water performances, Houston Mermaids also offer land-based entertainment, featuring storytelling, musical performances, themed games, and interactive character interactions that engage and delight audiences.

Customers have praised the immersive experience provided by Houston Mermaids. Rebecca S., who recently hosted a mermaid-themed party for her daughter, shared her experience: “We did a dry land party for my daughter’s 6th birthday, and it was an absolute hit! Mermaid Luna was fabulous and beautiful! The girls were completely engrossed and engaged with her the entire time she was there. Her surprise entrance on a rolling chair was the highlight of the party! Mermaid Luna sang songs, read them a story, played games, and put beautiful (and tasteful) shimmer makeup on the girls. She adjusted the program of the party based on what the girls wanted to do and had the cutest impromptu conversations with them throughout the visit.”

As summer heats up, Houston Mermaids invites families, event planners, and businesses to add a touch of magic to their celebrations. By blending fantasy, performance, and interactive entertainment, Houston Mermaids creates an experience that is both whimsical and unforgettable.

For more information about Houston Mermaids and to book an event, visit https://houstonmermaids.com.

About Houston Mermaids

Houston Mermaids is the leading mermaid entertainment company in Houston, Texas, specializing in immersive, high-quality performances for events of all kinds. With a team of skilled performers, Houston Mermaids offers water and land-based entertainment, bringing the magic of the ocean to any celebration. Serving Houston and surrounding areas, Houston Mermaids is committed to delivering unique, interactive experiences that create lasting memories.

Media Contact
Company Name: Houston Mermaids
Email: Send Email
Phone: 713-480-0224
Country: United States
Website: https://houstonmermaids.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Houston Mermaids Brings the Magic of the Sea to Summer Celebrations

Alex Kajumulo Unveils New Single Celebrating the Power of Music and Human Unity

Alex Kajumulo Unveils New Single Celebrating the Power of Music and Human Unity
An Anthem for Togetherness and Joy, Bringing Cultures and People Closer Together

On November 3, 2025, Alex Kajumulo, known for his rich connection to Tanzanian roots and vibrant musical journey, releases a compelling new single designed to unite and uplift. Emphasizing the essential elements of togetherness, respect, and the shared human journey, this track encourages listeners to celebrate life in harmony. Through this powerful anthem, Kajumulo seeks to bring a dynamic message of unity and shared humanity to the forefront, reminding us all that “one love is the law.”

Kajumulo’s music resonates with the timeless truth that while we may speak in different tongues, we can all sing together in perfect harmony. His latest single, a cornerstone of his album “Indigenous Since Beginning of Time,” embodies the spirit of celebration, urging people of all genders, cultures, and colors to sing, dance, and revel in our collective journey as humans. As he emphasizes, it is only through mutual respect and recognition of our shared beginnings and ends that we can truly cherish the present. This ethos is masterfully woven into the fabric of the music itself—a day song of special beauty and enduring power that aims to foster global togetherness.

This single isn’t just a song; it’s a call to embrace the power of music as a unifying force. With its upbeat rhythm and inspiring lyrics, Kajumulo invites everyone to stand up, sing out, and find common ground through the universal language of music. Whether you’re listening alone or sharing it with others, the track promises to infuse your spirit with positivity and connection.

Don’t miss the opportunity to experience this captivating new release. Listen and share to help bring Alex Kajumulo’s vision of worldwide unity through music to life. Join in the movement and see firsthand how his music can inspire and encourage harmony across borders.

ABOUT

Alex Kajumulo, a proud son of a Tanzanian coffee farming family, channels the wisdom and vitality of his heritage into every note of his music. Having once walked three hours daily to reach school and chased a soccer dream across the globe, his diverse experiences contribute to the depth and authenticity of his artistry. After an illustrious career as a professional soccer player, Kajumulo settled in Seattle, Washington, where he seamlessly transitioned into music while coaching soccer and writing about the sport. His passion for music drives him to create profoundly uplifting and inclusive songs that resonate with listeners of all backgrounds, solidifying his place as an authentic voice for unity and joy.

LINKS

Official Website https://oneloveisthelaw.com/

YouTube https://youtu.be/4YjFUnzC-7I

Spotify https://open.spotify.com/album/50HySkKcijl1pdgwa6jZSH?si=_gmAwkekSKaXmDh8E4me8g

Last.fm https://www.last.fm/music/Alex+Kajumulo

SoundCloud https://m.soundcloud.com/alex-kajumulo

ReverbNation https://www.reverbnation.com/davynefosband/song/7157211-mambo-bado-alex-kajumulo-and-bushmen

Media Contact
Company Name: Alex Kajumulo the original bushman
Email: Send Email
Phone: 2067659907
Address:P.O. Box 23787
City: Seattle
State: Washington 98165
Country: United States
Website: https://oneloveisthelaw.com/